Revenue decreased 94.8%
Revenue changed -94.8% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Revenue changed -94.8% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Shares outstanding changed -6.0% from the comparable as-filed period. The change ranks at the 100th percentile of 8 prior comparable changes.
Stock-based compensation changed +498.2% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
SBC / revenue changed +3169 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Cash & equivalents changed -49.2% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Revenue changed -92.7% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Net income changed +55.3% from the comparable as-filed period.
Shares outstanding changed -3.7% from the comparable as-filed period. The change ranks at the 100th percentile of 8 prior comparable changes.
SBC / revenue changed +1765 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.